{"podcast":{"title":"Oncology Today with Dr Neil Love","slug":"oncology-today-with-dr-neil-love-1004241","podcast_index_feed_id":1004241,"rss_url":"https://feeds.captivate.fm/oncologytoday/","website_url":"https://www.researchtopractice.com","image_url":"https://artwork.captivate.fm/464a03b3-1b7f-4b39-a2c6-e3de4b1e77b7/8YAjpM6wBeZeb3Gyb3zbR3bE.jpg","author":"Dr. Neil Love","episode_count":463,"summary":"Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.","last_synced_at":"2026-07-28T06:21:37.419138+00:00","page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241"},"episode":{"title":"Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting","slug":"novel-therapies-for-non-hodgkin-lymphoma-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting","published_at":"2026-07-09T13:00:00+00:00","page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/novel-therapies-for-non-hodgkin-lymphoma-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting","show_page_url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241","url":"https://oncologytoday.captivate.fm/episode/6164-asco2026-nhl","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/d108747a-c8d0-4a3e-9a03-a81ce32f36fa.mp3","summary":"Featuring perspectives from Dr Christopher Flowers, Dr Matthew Lunning, Dr Sonali M Smith and Dr Brad S Kahl, moderated by Dr Kahl, including the following topics: Rational Incorporation of CD79b-Targeted Antibody-Drug Conjugates into the Management of Newly Diagnosed and Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Flowers (00:00) Clinical Utility of CD19-Directed Monoclonal Antibodies in the Treatment of DLBCL and Follicular Lymphoma (FL) — Dr Smith (31:41) Optimal Use of CD19-Directed Antibody-Drug Conjugates for R/R DLBCL and FL — Dr Lunning (01:03:23) Current and Future Role of Bruton Tyrosine Kinase Inhibition in Therapy for Non-Hodgkin Lymphoma — Dr Kahl (01:26:48) CME information an d select publications","meta_description":"Featuring perspectives from Dr Christopher Flowers, Dr Matthew Lunning, Dr Sonali M Smith and Dr Brad S Kahl, moderated by Dr Kahl, including the followin…","key_points":[],"chapters":[],"topics":[],"duration_seconds":7034,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/novel-therapies-for-non-hodgkin-lymphoma-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/novel-therapies-for-non-hodgkin-lymphoma-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}